Phibro Animal Health (PAHC) revenue breakdown
By segment, Animal Health is the largest at 77% of fiscal 2026 revenue, growing 10% a year over 9 years.
By product, MFAs and other is the largest at 53% of fiscal 2026 revenue, growing 20% a year over 5 years.
Revenue by segment
Fiscal years, as Phibro Animal Health reports them in its 10-K filings; fiscal 2026 total $1.5B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health | $498M | $532M | $532M | $527M | $546M | $607M | $660M | $706M | $963M | $1.2B | 77% |
| Mineral Nutrition | $218M | $235M | $234M | $214M | $221M | $260M | $243M | $244M | $253M | $282M | 19% |
| Performance Products | $48M | $53M | $62M | $59M | $67M | $76M | $75M | $68M | $80M | $74M | 5% |
Revenue by product
Fiscal years, as Phibro Animal Health reports them in its 10-K filings; fiscal 2026 total $1.5B.
| Products | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|
| MFAs and other | $330M | $362M | $387M | $421M | $646M | $811M | 53% |
| Mineral Nutrition | $221M | $260M | $243M | $244M | $253M | $282M | 19% |
| Nutritional Specialties | $143M | $157M | $173M | $165M | $179M | $195M | 13% |
| Vaccines | $73M | $88M | $100M | $121M | $137M | $156M | 10% |
| Performance Products | $67M | $76M | $75M | $68M | $80M | $74M | 5% |
Revenue by region
Fiscal years, as Phibro Animal Health reports them in its 10-K filings; fiscal 2026 total $1.5B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $484M | $491M | $480M | $472M | $495M | $562M | $579M | $585M | $740M | $877M | 58% |
| Latin America and Canada | $113M | $143M | $152M | $159M | $166M | $191M | $220M | $248M | $299M | $341M | 22% |
| Europe, Middle East and Africa | $96M | $110M | $105M | $112M | $114M | $122M | $118M | $122M | $160M | $188M | 12% |
| Asia Pacific | $71M | $75M | $90M | $57M | $58M | $67M | $61M | $63M | $97M | $112M | 7% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PAHC.
Open PAHC in InvestinglyQuestions
Where does Phibro Animal Health make its money?
In fiscal 2026, by segment: Animal Health $1.2B, Mineral Nutrition $282M, Performance Products $74M.
From Phibro Animal Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.